Patents for C07J 1 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, not substituted in position 17 beta by a carbon atom, e.g. oestrane, androstane (4,828) |
---|
08/12/1998 | CN1190404A Neuroactive steroids of androstane and pregnane series |
08/04/1998 | US5789607 Process for the preparation of 1,25-dihydroxy-16-ene-23-yne-cholecalciferol |
08/04/1998 | CA2101275C Methods for the treatment of osteoporosis |
07/30/1998 | WO1998032718A1 New fatty acid derivatives |
07/29/1998 | CN1039329C Process for preparing steroid esters compound |
07/29/1998 | CN1039328C D-high-(16-ene)-11 beta-aryl-4-estrene-3-ketonic-like compound preparing process |
07/23/1998 | WO1998031702A1 16-hydroxy-11-(substituted phenyl)-estra-4,9-diene derivatives |
07/23/1998 | WO1998031381A1 Compositions to enhance the cytoprotective effects of polycyclic phenolic compounds through the synergistic interaction with anti-oxidants |
07/23/1998 | CA2277924A1 16-hydroxy-11-(substituted phenyl)-estra-4,9-diene derivatives |
07/21/1998 | US5783571 Method of altering hypothalamic function by nasal administration of estrene steroids |
07/21/1998 | US5783208 Transdermal drug delivery matrix for coadministering estradiol and another steroid |
07/14/1998 | US5780460 Therapeutic methods and delivery systems utilizing sex steroid precursors |
07/07/1998 | US5776923 Method of treating or preventing osteoporosis by adminstering dehydropiandrosterone |
07/02/1998 | WO1998028322A1 Bissteroidal compounds and their use for the preparation of chiral complexes |
07/02/1998 | CA2275879A1 Bissteroidal compounds and their use for the preparation of chiral complexes |
06/24/1998 | EP0849274A1 Bissteroidal compounds and their use for the preparation of chiral complexes |
06/24/1998 | EP0848620A1 Agent, for transdermal application, containing esters of 3-ketodesogestrel |
06/23/1998 | US5770729 Sulfide compound with polar substituents, formation of sulfoxide, mild conditions, safe, nonpolluting |
06/23/1998 | CA1339924C 11beta-phenyl-14betha steroids |
06/18/1998 | WO1998025948A2 Processes for preparation of 9,11-epoxy steroids and intermediates useful therein |
06/18/1998 | CA2550897A1 Processes for preparation of 9,11-epoxy steroids and intermediates useful therein |
06/11/1998 | WO1998024448A1 METHOD OF PREVENTING NEURODEGENERATION AND COGNITIVE DYSFUNCTION USING 17α-DIHYDROEQUILENIN |
06/11/1998 | CA2272891A1 Method of preventing neurodegeneration and cognitive dysfunction using 17.alpha.-dihydroequilenin |
06/10/1998 | DE19723390C1 New 9-alpha-hydroxy-8-alpha-oestratriene derivatives |
06/09/1998 | US5763433 Pharmaceutical compositions containing 3-beta-hydroxylated 6,7-substituted steroid derivatives, and use thereof |
06/02/1998 | US5760255 Reacting with perfluoroalkylsulfonyl fluoride in presence of strong organic base in inert organic solvent |
06/02/1998 | US5760046 oral low daily dosage of FINASTERIDE; treating female hirsutism; promoting hair growth; hyperandrogenic conditions of acne vulgaris, seborrhea, polycystic ovary syndrome |
06/02/1998 | US5760025 Administering testosterone 5a-reductase inhibitors |
05/26/1998 | US5756490 Estrogen and gestagen |
05/20/1998 | CN1182368A Immanomodulating compositions from bile for treatment of immune system disorders |
05/06/1998 | CN1181077A Benzopyran-containing compounds and method for their use |
04/29/1998 | EP0837874A2 Neuroactive steroids of the androstane and pregnane series |
04/28/1998 | US5744462 Administering glucose-6-phosphate dehydrogenase inhibitor |
04/23/1998 | WO1998016544A1 8(9)-dehydroestradiol derivatives |
04/23/1998 | WO1998016543A1 Remedy for chronic fatigue syndrome |
04/23/1998 | CA2268330A1 8(9)-dehydroestradiol derivatives |
04/22/1998 | EP0429480B1 Natriuretic hormone |
04/21/1998 | US5741786 Steroids with a 17-spiromethylene lactone or lactol group |
04/16/1998 | WO1998015279A1 Hormonal composition consisting of an oestrogen compound and of a progestational compound |
04/15/1998 | EP0835113A1 Dehydroepiandrosterone derivatives for preventing progressive tissue necrosis reperfusion injury, bacterial translocation and adult respiratory distress syndrome |
04/14/1998 | US5739363 Using lithium salt of ethylenediamine or lithium amide in dimethyl sulfoxide |
04/14/1998 | US5739302 Subjecting acetoxyestrogen to fries rearrangement in presence of acetyl chloride, using dakin reaction to replace acetyl group with hydroxyl group at alkaline ph |
04/14/1998 | US5739125 Used to induce abortion or labor, or to treat endometrosis, dysmenorrhea, or progestin hormone-dependent tumors |
04/07/1998 | US5736537 Dehydroep:androsterone sailcylate useful against skin atrophy |
04/01/1998 | EP0716599B1 TRANSDERMAL THERAPEUTIC SYSTEM FOR THE RELEASE OF 17-$g(b)-ESTRADIOL AND PROCESS FOR ITS PRODUCTION |
04/01/1998 | EP0572451B1 Novel steroid esters |
03/19/1998 | WO1998011123A1 Carbamate-derivatized nucleosides and oligonucleosides |
03/18/1998 | EP0829263A1 Use of 8,9-dehydroestrone in estrogen therapy |
03/18/1998 | CN1037769C Process for extracting vitamin E and sterol from by-product after refining vegetable oil |
03/17/1998 | US5728689 11β-aryl-4-estrenes, process for their production as well as their use as pharmaceutical agents |
03/17/1998 | US5728688 Therapeutic methods and delivery systems utilizing sex steroid precursors |
03/16/1998 | CA2215655A1 Use of 8,9-dehydroestrone as an estrogen with neutral effects on prolactin levels |
03/12/1998 | WO1998005679A3 Mixed agonists of the progesterone receptor and assays therefor |
03/11/1998 | CN1175903A Method of treating adenosine depletion |
03/10/1998 | US5725840 Steroidal ester contrast media for x-ray and magnetic resonance imaging |
03/04/1998 | EP0700293B1 Dihydrotestosterone for use in androgenotherapy |
03/03/1998 | US5723455 Contraceptives |
03/03/1998 | US5723454 Membrane filtration using adsoorber resin, washing with water and elution liquid, desorption with ether, alcohol or ketone |
02/25/1998 | EP0825197A2 New 6-hydroxy and 6-oxo-anstro-stane derivatives active on the cardiovascular system and pharmaceutical compositions containing same |
02/25/1998 | EP0824346A2 Use of sesquiterpenes for inhibiting oxidative enzymes |
02/24/1998 | US5721227 17-aryl and 17-heterocyclyl-14β-5α-androstane, androstene and androstadiene derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing same |
02/24/1998 | CA2086919C Process for the production of unsaturated 17.alpha.-cyanomethyl -17.beta. hydroxy steroids |
02/18/1998 | EP0823897A1 Nicotinic acid esters and pharmaceutical compositions containing them |
02/18/1998 | EP0823895A1 Fatty acid esters as bioactive compounds |
02/18/1998 | EP0823889A1 1,3-propane diol derivatives as bioactive compounds |
02/17/1998 | US5719300 Process for the preparation of gestodene |
02/17/1998 | US5719137 Method of preventing neurodegeneration and cognitive dysfunction using 17α-dihydroequilenin |
02/12/1998 | WO1998005679A2 Mixed agonists of the progesterone receptor and assays therefor |
02/10/1998 | US5717088 Method of making steroid derivatives for the treatment of prostatic hypertrophy |
02/05/1998 | WO1998004577A1 PROCESS FOR PREPARING 16α-HYDROXY-ESTRA-1,3,5(10)-TRIENE DERIVATIVES |
02/05/1998 | CA2260121A1 Process for preparing 16.alpha.-hydroxy-estra-1,3,5(10)-triene derivatives |
02/04/1998 | EP0655916B1 Transdermal application agent containing 3-keto-desogestrel |
02/03/1998 | US5714481 Administering to mammalian host a glucose-6-phsophate dehydrogenase inhibitor, anticarcinogenic, antiobasity, anti-hyperglycemic, antiaging, anticholesterol and anti-autoimmune agent |
01/29/1998 | WO1998003137A1 Transdermal drug delivery matrix for coadministering estradiol and another steroid |
01/22/1998 | WO1998002450A2 6,7-oxygenated steroids and uses related thereto |
01/20/1998 | US5710144 Osteoporosis |
01/20/1998 | US5709881 Tablet capsule or granule comprising desogestrel |
01/15/1998 | DE19626400A1 1,4-Addition of alkyl to unsaturated carbonyl compound |
01/14/1998 | EP0684825A4 Method of preventing or inhibiting fertilization. |
01/14/1998 | CN1170353A Intravaginal drug delivery devices for the administration fo 17 'beta'-oestradiol precursors |
01/07/1998 | EP0814821A1 Immunomodulating compositions from bile for the treatment of immune system disorders |
01/06/1998 | US5705494 Anti-estrogenic activity of IIβ-substituted-19-NOR Steroids |
01/06/1998 | US5705335 Design of drugs involving receptor-ligand-DNA interactions |
12/31/1997 | WO1997049407A1 Progestogen-anti-progestogen regimens |
12/31/1997 | CN1168876A Method for prepn. of steroid derivative ketal |
12/31/1997 | CN1036835C Method for prepn. of multiple step combination type contraceptive |
12/31/1997 | CN1036833C Method for prepn. of multiple step contraceptive |
12/31/1997 | CA2255863A1 Progestogen-anti-progestogen regimens |
12/23/1997 | US5700793 An androstane-17-one and ene steroids; hypoglycemic agent, anticholesterol agent; treating autoimmune diseases |
12/10/1997 | EP0811006A1 Benzopyran-containing compounds and method for their use |
12/10/1997 | EP0810863A1 Method of treating adenosine depletion |
12/10/1997 | CN1167489A Novel estrenes for inducing hypothalamic effects |
12/09/1997 | US5696107 Administering androsten-3-ol |
12/09/1997 | US5696106 Steroids useful as anti-cancer and anti-obesity agents |
12/09/1997 | CA1339570C New 11-aryl steroid derivatives |
12/04/1997 | WO1997045441A1 7α-(5-METHYLAMINOPENTYL)-ESTRATRIENES, PROCESS FOR THE PREPARATION THEREOF, PHARMACEUTICAL PREPARATIONS WHICH CONTAIN SAID 7α-(5-METHYLAMINOPENTYL)-ESTRATRIENES AND USE THEREOF FOR PRODUCTION OF DRUGS |
12/04/1997 | WO1997037664A3 Use of 7 alpha-substituted steroids to treat neuropsychiatric, immune or endocrine disorders |
12/04/1997 | CA2256344A1 7.alpha.-(5-methylaminopentyl)-estratrienes, process for their production, pharmaceutical preparations that contain these 7.alpha.-(5-methylaminopentyl)-estratrienes as well as their use for the production of pharmaceutical agents |
12/03/1997 | CN1166836A Novel androstanes with inducing hypothalamic effects |
12/03/1997 | CN1036591C Carbamates of repamycin |